Join us Dec. 1-3 in New Orleans for the Digiday Programmatic Marketing Summit
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
TikTok dangles cash, credits and fully-funded deals to supercharge U.S. Shop spending
The platform has shared a plethora of incentives, to motivate sellers to spend more money.
Agencies are racing to offer zero-click analysis tools, but monetizing them isn’t easy
Marketing services companies are rushing to answer clients’ zero-click queries. The jury’s out on whether clients will pay for those answers, however.
Influencer partnerships expand, though unevenly across the creator economy
The result is a creator economy caught between maturity and hesitation — growing up fast but not all at once.